Differences in severity of poison centers exposures involving XTAMPZA( ®) ER versus other opioid analgesics - Severtson SG, Haanschoten EE, Iwanicki J, Dart RC.

Aims: Xtampza( ®) ER (Collegium Pharmaceutical, MA, USA) is an abuse-deterrent formulation (ADF) of oxycodone intended to deter tampering for use by unintended routes of administration. We assessed whether Xtampza ER exposures were less likely to result in ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news